At a glance
- Originator Eli Lilly and Company; Lundbeck Research USA
- Class Small molecules; Tryptamines
- Mechanism of Action Serotonin 1D receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Migraine
Most Recent Events
- 28 Aug 2000 Preclinical development for Migraine in USA (Unknown route)